Conseils en matière d'accès aux marchés et HEOR
Generate evidence to optimize access and enable commercial success.
You need clarity on your product's value early. We generate robust evidence, demonstrating value to stakeholders. Partner with us to ensure your product meets regulatory, provider, payer, policymaker and patient expectations-optimizing your commercial opportunities.
Pursue outcomes, value and access initiatives
Develop a strategy and generate data to meet the needs of all stakeholders.
Enhance your commercial opportunities
Grow understanding of your product’s clinical, economic and patient-centered value, and generate evidence to increase your likelihood of access.
Work with an interdisciplinary team
Get tailored solutions to meet your product’s needs at every stage of development.
A forward-thinking approach to evidence and value
Are you in Phase I or looking ahead to late phase and post-approval? We help ensure your product's policymakers and patients, identifying evidence gaps and creating custom projects to support your product. Using their expertise in epidemiology, real-world evidence, health economics, outcomes research, patient-centered assessment, biostatistics, reimbursement, access strategy and value demonstration, our market access and HEOR consultants craft strategies that highlight your product's unique value.
Access a suite of complementary solutions
Enhance your value, evidence and access strategies with our comprehensive solutions:
- Real-world data (RWD) and real-world evidence (RWE)
- Post-hoc and payer-focused analytics
- Patient-centered research and assessment
- Health economics and modeling
- HTA strategy and submissions
- Value demonstration and communication
- Reimbursement strategy and payer insights
- Market access landscape assessment
- Digital and design solutions
- Digital health strategy
Work with an experienced partner
We've executed thousands of projects and demonstrated our expertise through hundreds of peer-reviewed publications. Our subject matter experts span three continents, with advanced degrees and decades of hands-on experience. We help you by:
- Understanding market access in your target regions to advise on strategy, evidence needs and solutions
- Developing patient-centered endpoints to measure treatment benefit, per the FDA’s Patient-Focused Drug Development program
- Collecting and analyzing RWD on natural history, incidence/prevalence, effectiveness and safety
- Conducting post-hoc analyses for economic modeling and payer reimbursement
- Identifying your product’s key value attributes and determining post registration evidence needs
- Creating impactful communication tools to showcase your product’s value to market access decision-makers
